Related references
Note: Only part of the references are listed.Identification of tumor antigens with immunopeptidomics
Chloe Chong et al.
NATURE BIOTECHNOLOGY (2022)
Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy
Meng Wang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy
Jie Chen et al.
BIOACTIVE MATERIALS (2022)
White Blood Cell Membrane-Coated Nanoparticles: Recent Development and Medical Applications
Dan Wang et al.
ADVANCED HEALTHCARE MATERIALS (2022)
Engineered extracellular vesicles for concurrent Anti-PDL1 immunotherapy and chemotherapy
Yundi Chen et al.
BIOACTIVE MATERIALS (2022)
Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis
Xu Wang et al.
NATURE COMMUNICATIONS (2021)
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study
Nehal J. Lakhani et al.
LANCET ONCOLOGY (2021)
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
Rachna T. Shroff et al.
NATURE MEDICINE (2021)
Engineering biomimetic epigenetic nanoinducer improves cancer immunotherapy
Yuliang Zhao
SCIENCE CHINA-CHEMISTRY (2021)
Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles
Jing Qi et al.
NATURE COMMUNICATIONS (2021)
Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs
Joon Ho Park et al.
SCIENCE ADVANCES (2021)
Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo
Huapan Fang et al.
NATURE COMMUNICATIONS (2021)
Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
Vaccination with CD47 deficient tumor cells elicits an antitumor immune response in mice
Yang Li et al.
NATURE COMMUNICATIONS (2020)
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Mark P. Chao et al.
FRONTIERS IN ONCOLOGY (2020)
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis
Meghan A. Morrissey et al.
IMMUNITY (2020)
The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency
Xiaoyu Hong et al.
SCIENCE ADVANCES (2020)
Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Qingyang Lei et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Highly Enhanced Antitumor Immunity by a Three-Barreled Strategy of the L-Arginine-Promoted Nanovaccine and Gene-Mediated PD-L1 Blockade
Yingying Hu et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
Lynette Sholl et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Synergistic tumor immunological strategy by combining tumor nanovaccine with gene-mediated extracellular matrix scavenger
Yingying Hu et al.
BIOMATERIALS (2020)
Choice of Nanovaccine Delivery Mode Has Profound Impacts on the Intralymph Node Spatiotemporal Distribution and Immunotherapy Efficacy
Jianghua Wang et al.
ADVANCED SCIENCE (2020)
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fucikova et al.
CELL DEATH & DISEASE (2020)
Glycopolymers/PEI complexes as serum-tolerant vectors for enhanced gene delivery to hepatocytes
Liman Zhao et al.
CARBOHYDRATE POLYMERS (2019)
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
Branimir Sikic et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
T cell stemness and dysfunction in tumors are triggered by a common mechanism
Suman Kumar Vodnala et al.
SCIENCE (2019)
Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy
Francesca Castoldi et al.
ONCOIMMUNOLOGY (2019)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression (vol 19, pg 1189, 2017)
Angel Garcia-Diaz et al.
CELL REPORTS (2019)
Zinc ion coordination significantly improved the transfection efficiency of low molecular weight polyethylenimine
Huapan Fang et al.
BIOMATERIALS SCIENCE (2019)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy
Andre Veillette et al.
TRENDS IN IMMUNOLOGY (2018)
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young et al.
CANCER RESEARCH (2018)
A Pt(IV)-mediated polymer architecture for facile and stimuli-responsive intracellular gene silencing with chemotherapy
Sungjin Jung et al.
BIOMATERIALS SCIENCE (2018)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
Paola A. Betancur et al.
NATURE COMMUNICATIONS (2017)
Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity
Ashley V. Kroll et al.
ADVANCED MATERIALS (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Ionic immune suppression within the tumour microenvironment limits T cell effector function
Robert Eil et al.
NATURE (2016)
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Antoni Ribas
CANCER DISCOVERY (2015)
Bispecific antibody targeting of CD47/CD19 to promote enhanced phagocytosis of patient B lymphoma cells.
Zoe Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Ronnie H. Fang et al.
NANO LETTERS (2014)
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
Julia Scheiermann et al.
VACCINE (2014)
Vaccine Injection Site Matters: Qualitative and Quantitative Defects in CD8 T Cells Primed as a Function of Proximity to the Tumor in a Murine Glioma Model
John R. Ohlfest et al.
JOURNAL OF IMMUNOLOGY (2013)
Adenosine receptors:: therapeutic aspects for inflammatory and immune diseases
Gyorgy Hasko et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly
AW Orr et al.
JOURNAL OF CELL BIOLOGY (2003)